Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
19.90
+0.05 (0.25%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Jade Biosciences Employees
Jade Biosciences had 55 employees as of December 31, 2025. The number of employees increased by 25 or 83.33% compared to the previous year.
Employees
55
Change
25
Growth
83.33%
Revenue / Employee
n/a
Profits / Employee
-$2,262,582
Market Cap
1.27B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 55 | 25 | 83.33% |
| Dec 31, 2024 | 30 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 704 |
| MannKind | 592 |
| MeiraGTx Holdings | 393 |
| Kura Oncology | 260 |
| Monte Rosa Therapeutics | 173 |
| MoonLake Immunotherapeutics | 130 |
| Janux Therapeutics | 113 |
| ORIC Pharmaceuticals | 111 |
JBIO News
- 4 days ago - Jade Biosciences price target raised to $48 from $25 at Clear Street - TheFly
- 6 days ago - Jade Biosciences to Participate in Upcoming Conferences - GlobeNewsWire
- 27 days ago - Jade Biosciences price target raised to $48 from $40 at Jefferies - TheFly
- 27 days ago - Jade Biosciences price target raised to $47 from $45 at Wedbush - TheFly
- 4 weeks ago - Jade Biosciences Slides: Company presentation - Filings
- 4 weeks ago - Jade Biosciences reports Q2 EPS (76c) vs. (86c) last year - TheFly
- 4 weeks ago - Jade Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Jade Biosciences Earnings release: Q2 2026 - Filings